全球生物活性材料市场的应用、类型、最终用户、区域范围和预测

全球生物活性材料市场规模及预测

预计 2024 年全球生物活性材料市场价值将达到 22.2 亿美元，2031 年将达到 56.8 亿美元，2024 年至 2031 年的复合年增长率为 12.49%。

生物活性材料是与生物系统相互作用并触发特定反应（例如组织再生和癒合）的化合物。

由于它们能够与活组织相互作用并改善生物过程，因此已被用于各种应用，包括医疗植入、牙科治疗、创伤治疗和药物传输系统。

正在进行的研究、开发和技术进步有望扩大再生医学、个人化医疗保健和创新治疗的应用，从而为各种疾病带来更有效、生物相容的解决方案。

生物活性材料的全球市场动态

影响全球生物活性材料市场的关键市场动态包括：

主要市场驱动因素：

老化社会与慢性病的流行：老龄人口的成长是生物活性材料发展的主要驱动力。根据世界卫生组织（WHO）的数据，2015年至2050年期间，全球60岁以上人口的比例将增加近一倍，从12%增加到22%。从绝对数量来看，这将使60岁及以上人口的数量从9亿增加到20亿。这种人口结构的变化与慢性病的发生率上升相吻合。根据世界卫生组织（WHO）的数据，慢性病占全球整体死亡人数的71%，这推动了医疗应用对生物活性材料的需求。

医疗技术的进步：生物技术和奈米技术的进步正在推动新型生物活性材料的研发，其生物相容性、生物活性和机械强度等性能均有所提升。这些技术突破正在拓展生物活性材料在整形外科、牙科和再生医学等各个医疗领域的应用。

微创手术日益受到重视：微创手术技术的应用，缩短了恢復时间，降低了併发症风险，推动了对生物活性材料的需求。这些材料对于製造加速癒合和增强组织整合的微创植入和器械至关重要。

新兴市场对生物活性材料的认知度和应用度不断提升：新兴经济体对生物活性材料益处的认知度不断提升，以及医疗保健投资的不断增加，正在推动市场扩张。随着亚太地区和拉丁美洲医疗基础设施的不断发展，生物活性材料等创新医疗技术的使用预计将呈指数级增长。

主要挑战

高昂的开发和生产成本：生物活性材料的开发和生产成本高。根据塔夫茨大学医学研究与发展中心2023年的研究，开发一种经常使用生物活性物质的新药的平均成本为26亿美元。如此高成本可能会阻碍其广泛应用，尤其是在贫穷国家。世界卫生组织（WHO）在2021年预测，自付医疗费用每年将使超过1亿人陷入极端贫困，凸显了医疗负担能力的严峻性。

监管障碍和核准流程：生物活性物质受到严格的监管审查。根据美国食品药物管理局(FDA) 的数据，2022 年新医疗设备的核准中位数时间为 290 天，而 2018 年为 243 天，这反映出法律规范日益复杂。欧洲药品管理局 (EMA) 在 2022 年年度报告中报告称，其收到了 89 份新药申请，这表明需要监管审查的新产品数量持续增加。

技术挑战和性能限制：儘管生物活性材料取得了进展，但仍面临技术障碍。美国国家标准与技术研究院 (NIST) 报告称，2024 年，约 30% 的在研生物活性材料未达到长期稳定性标准。他们还指出，提高生物活性材料的机械强度以匹配天然组织仍然是一项重大挑战，目前的材料只能达到许多应用所需强度的 70-80%。

认知度和接受度有限：儘管人们对生物活性材料的认知度正在不断提高，但一些医疗专业人士和公众仍然缺乏理解和接受。这种情况在仍在使用传统材料和程序的地区尤为明显。消除疑虑并向相关人员普及生物活性材料的益处和潜力，对于产业发展至关重要。

主要趋势：

奈米技术整合：奈米技术在生物活性材料中的应用正在改变整个产业。奈米材料具有独特的特性，例如更大的表面积、更高的生物活性以及在细胞和分子层面相互作用的能力。这种整合有助于创造更有效、更集中的治疗方法，尤其是在药物传递系统和组织工程领域。

抗菌生物活性材料：人们对生产具有固有抗菌能力的生物活性材料的兴趣日益浓厚。世界卫生组织 (WHO) 预测，如果不采取任何措施，到 2050 年，抗生素抗药性将导致每年 1,000 万人死亡。这推动了抗菌生物活性材料的研究。根据 2023 年发表在《材料化学 B 期刊》上的一项研究，2019 年至 2023 年间，抗菌生物活性材料的研究出版物数量增加了 45%。

个人化和精准医疗：生物活性材料市场受到个人化和精准医疗趋势的影响。客製化生物活性材料的生产旨在满足个别患者的特定需求，从而提高医疗治疗的疗效和成功率。这一趋势在整形外科和牙科领域尤其明显，患者客製化的植入和植体正变得越来越普遍。

永续性和生物相容性：永续性和生物相容性在生物活性材料的开发中正日益成为重要的考虑因素。研究人员和生产商正在努力开发不仅有效，而且环保且生物相容的材料。这包括使用天然和可生物降解的成分，这些成分副作用更少，更容易被人体吸收和分布。

目录

第一章 引言

• 市场定义
• 市场区隔
• 调查方法

第二章执行摘要

• 主要发现
• 市场概况
• 市集亮点

第三章 市场概况

• 市场规模和成长潜力
• 市场趋势
• 市场驱动因素
• 市场限制
• 市场机会
• 波特五力分析

第四章生物活性材料市场（按类型）

• 生物活性玻璃
• 生物活性陶瓷
• 生物活性复合材料
• 其他的

第五章生物活性材料市场（依应用）

• 整形外科、牙科
• 奈米医学、生物技术
• 其他的

第六章生物活性材料市场（按行业）

• 医疗保健和生物医学
• 化妆品和个人护理
• 食品和农业

第七章区域分析

• 北美洲
• 美国
• 加拿大
• 墨西哥
• 欧洲
• 英国
• 德国
• 法国
• 义大利
• 亚太地区
• 中国
• 日本
• 印度
• 澳洲
• 拉丁美洲
• 巴西
• 阿根廷
• 智利
• 中东和非洲
• 南非
• 沙乌地阿拉伯
• 阿拉伯聯合大公国

第八章市场动态

• 市场驱动因素
• 市场限制
• 市场机会
• COVID-19 市场影响

第九章 竞争态势

• 主要企业
• 市占率分析

第十章：公司简介

• Zimmer Biomet
• Stryker Corporation
• DePuy Synthes（Johnson & Johnson）
• Medtronic
• GELITA AG
• Baxter International Inc.
• Angstrom Medica
• Nanovis LLC
• Arthrex Inc.
• Berkeley Advanced Biomaterials Inc.
• Biomet Inc.
• CAM Bioceramics BV

第十一章 市场展望与机会

• 新兴技术
• 未来市场趋势
• 投资机会

第十二章 附录

• 简称列表
• 来源和参考文献

Global Bioactive Materials Market Size and Forecast

Global Bioactive Materials Market size was valued at USD 2.22 Billion in 2024 and is projected to reach USD 5.68 Billion by 2031, growing at a CAGR of 12.49% from 2024 to 2031.

Bioactive materials are compounds that interact with biological systems, eliciting a specific response, such as tissue regeneration or healing.

They are employed in a variety of applications, including medical implants, dental care, wound healing, and drug delivery systems, because of their capacity to interact with biological tissues and improve biological processes.

The future of bioactive materials is vast, with ongoing research and technological advancements poised to expand their use in regenerative medicine, personalized healthcare, and innovative medical treatments, resulting in the development of more effective and biocompatible solutions for a wide range of conditions.

Global Bioactive Materials Market Dynamics

The key market dynamics that are shaping the global bioactive materials market include:

Key Market Drivers:

Aging Population and Increasing Prevalence of Chronic Diseases: The rising senior population is a major driver of bioactive materials. According to the World Health Organization (WHO), the proportion of the global population over the age of 60 will nearly double between 2015 and 2050, from 12% to 22%. In absolute terms, this represents a rise from 900 million to 2 billion people over the age of sixty. This demographic transition coincides with a rise in chronic diseases. According to the World Health Organization, chronic diseases account for 71% of all deaths worldwide, increasing the demand for bioactive materials in medical applications.

Advancements in Medical Technology: Rising advances in biotechnology and nanotechnology are resulting in the creation of new bioactive materials with improved features such as biocompatibility, bioactivity, and mechanical strength. These technical breakthroughs broaden the use of bioactive materials in a variety of medical sectors, including orthopedics, dentistry, and regenerative medicine.

Increasing Emphasis on Minimally Invasive Procedures: The transition to less invasive surgical techniques, which have shorter recovery times and decreased risk of problems, increases demand for bioactive materials. These materials are essential for creating minimally invasive implants and devices that enable faster healing and greater integration with biological tissues.

Rising Awareness and Adoption of Bioactive Materials in Emerging Markets: Growing awareness of the benefits of bioactive materials, as well as increased healthcare investment in emerging nations, are driving market expansion. As healthcare infrastructure develops throughout Asia-Pacific and Latin America, the use of innovative medical technology, such as bioactive materials, is predicted to increase dramatically.

Key Challenges:

High Costs of Development and Production: Bioactive materials have high development and production costs. According to a 2023 research by the Tufts Center for the Study of medicine Development, the average cost of developing a new medicine, which frequently incorporates bioactive materials, is USD 2.6 Billion. This high cost may impede wider use, especially in poor countries. The World Health Organization projected in 2021 that out-of-pocket health spending pushes over 100 million people into extreme poverty each year, highlighting the difficulty of healthcare affordability.

Regulatory Hurdles and Approval Processes: Bioactive materials are subject to strict regulatory monitoring. According to the United States Food and Drug Administration (FDA), the median time to clearance for new medical devices in fiscal year 2022 was 290 days. For instance, in 2018, the figure was 243 days, reflecting an increasingly complicated regulatory framework. The European medications Agency (EMA) reported in its 2022 annual report that it received 89 applications for new medications, illustrating the ongoing influx of new goods that require regulatory review.

Technical Challenges and Performance Limitations: Despite developments, bioactive materials continue to encounter technical hurdles. The National Institute of Standards and Technology (NIST) reported in 2024 that around 30% of bioactive materials in development do not meet long-term stability standards. The paper also stated that enhancing the mechanical strength of bioactive materials to match natural tissues is still a big problem, with current materials only achieving 70-80% of the needed strength in many applications.

Limited Awareness and Acceptance: While there is increasing awareness of bioactive materials, some healthcare professionals and people continue to lack understanding and acceptability. This is especially true in locations where traditional materials and procedures are still used. Overcoming skepticism and educating stakeholders about the benefits and possibilities of bioactive materials is critical to industry growth.

Key Trends:

Integration of Nanotechnology: The introduction of nanotechnology into bioactive materials is transforming the industry. Nanomaterials have distinct features such as expanded surface area, greater bioactivity, and the capacity to interact at both the cellular and molecular levels. This integration is helping to produce more effective and focused medical treatments, particularly in drug delivery systems and tissue engineering.

Antimicrobial Bioactive Materials: There is an increasing interest in producing bioactive materials with inherent antibacterial capabilities. The World Health Organization forecasts that if no action is taken, antibiotic resistance will kill 10 million people each year by 2050. This has prompted studies into antibacterial bioactive materials. A study published in the Journal of Materials Chemistry B in 2023 found that research publications on antibacterial bioactive materials increased by 45% between 2019 and 2023.

Personalized and Precise Medicine: The bioactive materials market is being influenced by the trend towards personalized and precision medicine. Customized bioactive materials are being produced to meet the specific demands of individual patients, hence increasing the effectiveness and outcomes of medical therapies. This trend is especially noticeable in orthopedics and dental care, where patient-specific implants and grafts are becoming increasingly common.

Sustainable and Biocompatible: Sustainability and biocompatibility are increasingly important considerations in the creation of bioactive materials. Researchers and producers are working to develop materials that are not only effective, but also eco-friendly and biocompatible. This includes the use of natural and biodegradable ingredients that cause fewer adverse effects and are securely integrated or absorbed by the body.

Global Bioactive Materials Market Regional Analysis

Here is a more detailed regional analysis of the global bioactive materials market:

Asia Pacific:

The Asia Pacific region is experiencing the fastest growth in the bioactive materials market, owing to a combination of positive factors. A growing population, notably in China and India, is driving a strong need for innovative medical solutions.

This demand is exacerbated by increase in healthcare spending in these countries, where both the government and private sector engage in upgrading healthcare infrastructure and accessibility. Another important market driver is the rising frequency of chronic disorders such as orthopedic and cardiovascular diseases.

Bioactive materials provide novel therapy options for various disorders, enabling faster healing, increased functionality, and potentially minimizing the need for additional procedures. Supportive government measures are critical to boosting industry growth. These programs focus on development.

North America:

North America dominates the global bioactive materials market, with the United States at the top. This supremacy is the result of a combination of favorable factors. A strong healthcare infrastructure, including well-equipped hospitals, trained medical workers, and cutting-edge medical technologies, creates an ideal environment for the adoption of innovative bioactive materials.

Furthermore, significant investments in R&D by both public and commercial enterprises drive ongoing innovation in this field. Furthermore, a supportive regulatory framework that prioritizes safety and efficacy promotes market expansion.

Aside from its robust infrastructure, North America's demographic trends help it lead the bioactive materials market. A big and expanding older population, combined with an increasing frequency of chronic disorders including orthopedic ailments and cardiovascular diseases, considerably strengthens the There is a high need for sophisticated medical gadgets and implants made using bioactive materials. This demand is fueled by rising healthcare spending, as consumers and insurance companies grow more open to innovative treatment choices that enhance patient outcomes while potentially lowering long-term healthcare expenditures.

Finally, the presence of a large number of significant market players in North America reinforces the region's supremacy. These prominent companies not only invest extensively in R&D, but also form strategic alliances and partnerships to speed up the development and commercialization of next-generation bioactive materials. This fierce rivalry creates a dynamic and innovative atmosphere, moving the market ahead.

Global Bioactive Materials Market: Segmentation Analysis

The Global Bioactive Materials Market is segmented on the basis of By Application, By Type, By End-User, and By Geography.

Global Bioactive Materials Market, By Application

Orthopedics

Dental Care

Nanomedicines & Biotechnology

Based on Application, the Global Bioactive Materials Market is segmented into Orthopedics, Dental Care, and Nanomedicines & Biotechnology. The orthopedics segment dominates due to the widespread usage of bioactive materials in bone healing, joint replacement, and spinal implants. The growing prevalence of orthopedic ailments, combined with an aging population, is driving demand in this category. Nanomedicines & Biotechnology is the fastest-growing segment, spurred by advances in nanotechnology and its use in targeted medication delivery and regenerative medicine. The increased emphasis on customized medicine and innovative therapeutic solutions is driving the segment's rapid growth.

Global Bioactive Materials Market, By Type

Bioactive Glass

Bioactive Ceramics

Bioactive Composites

Based on Type, the Global Bioactive Materials Market is segmented into Bioactive Glass, Bioactive Ceramics, and Bioactive Composites. The bioactive glass segment dominates due to its widespread use in bone regeneration, dental care, and tissue engineering. The segment's exceptional features, including as biocompatibility and capacity to bind with bone, make it a popular choice for medical treatments. Bioactive Composites is the fastest-growing segment, thanks to their many uses and the growing need for sophisticated, multifunctional materials in both medical and dentistry fields. Their capacity to combine various bioactive components to improve performance drives their rapid growth.

Global Bioactive Materials Market, By End-User

Healthcare & Biomedical

Cosmetics & Personal Care

Food & Agriculture

Based on End-User, the Global Bioactive Materials Market is segmented into Healthcare & Biomedical, Cosmetics & Personal Care, and Food & Agriculture. The healthcare & biomedical segment is dominating, owing to the widespread usage of bioactive materials in medical implants, tissue engineering, and drug delivery devices. The ongoing improvements in medical technology, as well as the growing need for novel healthcare solutions, maintain this segment's leadership position. Cosmetics & personal care is the fastest-growing segment, driven by rising customer demand for products containing bioactive compounds that provide better skin care benefits and anti-aging qualities. Growing knowledge of the efficacy and safety of bioactive compounds in cosmetics is driving the segment's rapid growth.

Global Bioactive Materials Market, By Geography

North America

Europe

Asia Pacific

Rest of the World

Based on the Geography, the Global Bioactive Materials Market are classified into North America, Europe, Asia Pacific, and Rest of the World. North America is the dominating region, owing to superior healthcare infrastructure, significant R&D investments, and the presence of key industry players. This region benefits from major technological breakthroughs and a strong emphasis on innovative medical solutions, which contribute to its dominant position. Asia Pacific is the fastest-growing area, driven by expanding demand for innovative medical treatments, rising healthcare costs, and rapid industrialization. The increased awareness of the benefits of bioactive materials, as well as the expansion of medical tourism, contribute to the market's quick rise in this region.

Key Players

The "Global Bioactive Materials Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Zimmer Biomet, Stryker Corporation, DePuy Synthes (Johnson & Johnson), Medtronic, GELITA AG, Baxter International Inc., Angstrom Medica.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

• Global Bioactive Materials Market: Recent Developments
• In January 2024, Italian biomaterials startup Mogu, which will shortly be rebranded Sqim, has raised €11 million (USD 12 Million) in Series A funding from French fashion giant Kering to grow its mycelium-based technology. Mogu plans to utilize the financing to establish a prototype production plant, grow its personnel, and extend its research and development of mycelium-based goods for areas such as fashion and automotive.
• In January 2024, Xenco Medical showcased their TrabeculeX Continuum(TM), a convergent technology that connects digital health and biomaterials, at the 2024 Consumer Electronics Show in Las Vegas, Nevada. The TrabeculeX Continuum, which includes the FDA-cleared TrabeculeX Bioactive Matrix(TM) and TrabeculeX Recovery App(TM), is the first technology-enabled bridge between orthobiologics and digital health. It unifies a patient's biomaterial implantation and postoperative experience. The TrabeculeX Continuum enables surgeons who have implanted Xenco Medical's FDA-cleared TrabeculeX Bioactive Matrix to enroll patients in the TrabeculeX Recovery App and engage in both Remote Therapeutic Monitoring and asynchronous video and text messaging. It is an unprecedented intersection of regenerative medicine and digital health.
• In July 2023, DSM Biomedical has introduced a unique bioactive ceramic material for dental and orthopedic implants. This material is designed to improve Osseo integration and promote quicker healing, addressing the growing demand for effective and dependable implant materials.
• In September 2023, Medtronic has revealed a breakthrough in bioactive coatings for medical implants, with a focus on increasing the biocompatibility and performance of cardiovascular and orthopedic implants. This development intends to lower the likelihood of implant rejection while also improving implant integration with neighboring tissues.
• In October 2023, Schott AG announced the creation of a new generation of bioactive glass materials intended for dentistry and orthopedic applications. This novel bioglass has higher bioactivity and mechanical strength, making it ideal for a wider range of medical applications.

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Bioactive Materials Market, By Type

• Bioactive Glass
• Bioactive Ceramics
• Bioactive Composites
• Others

5. Bioactive Materials Market, By Application

• Orthopedics, Dental Care
• Nanomedicines and Biotechnology
• Others

6. Bioactive Materials Market, By Industry

• Healthcare & Biomedical
• Cosmetics & Personal Care
• Food & Agriculture

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Zimmer Biomet
• Stryker Corporation
• DePuy Synthes (Johnson & Johnson)
• Medtronic
• GELITA AG
• Baxter International Inc.
• Angstrom Medica
• Nanovis LLC
• Arthrex Inc.
• Berkeley Advanced Biomaterials Inc.
• Biomet Inc.
• CAM Bioceramics B.V.

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References